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Abstract
Background: Attention deficit hyperactivity disorder (ADHD) is increasingly recognized as a common disorder not
only in children, but also in the adult population. Similarly, asthma also has a substantial prevalence among adults.
Previous studies concerning a potential relationship between ADHD and asthma have not presented consistent
results.
Methods: A cross-sectional study of 594 adult patients diagnosed with ADHD, compared with 719 persons from
the general population. Information was collected between 1997 and 2005 using auto-questionnaires rating past
and present symptoms of ADHD, co-morbid conditions, including asthma, and work status.
Results: The prevalence of asthma was significantly higher in the ADHD patient group compared to the controls,
24.4% vs. 11.3% respectively (OR = 2.54, 95% CI 1.89-3.44), and controls with asthma scored higher on ratings of
both past and present symptoms of ADHD. Female ADHD patients had a significantly higher prevalence of asthma
compared to male ADHD patients (30.9% vs. 18.2%, OR = 2.01, CI 1.36-2.95), but in controls a slight female
preponderance was not statistically significant. In both ADHD patients and controls, having asthma was associated
with an increased prevalence of symptoms of mood- and anxiety disorders.
Conclusions: The present findings point to a co-morbidity of ADHD and asthma, and these patients may represent
a clinical and biological subgroup of adult patients with ADHD.
Background
Attention deficit hyperactivity disorder (ADHD) is a
common disorder in children causing substantial pro-
blems for those afflicted [1-3]. During the last 10-15
years ADHD has been the focus of increasing interest
also in adult psychiatry [2-4]. The prevalence of ADHD
is estimated to be in the range of 2-12% in children
[5-7] and 3-5% in adults [8,9]. Many children with
ADHD retain impairing symptoms as adults, causing
difficulties in relation to educational, social and occupa-
tional functioning [10,11]. In addition, ADHD is asso-
ciated with many other psychiatric disorders, in
particular anxiety- and mood disorders [9,11].
Like ADHD asthma is also perceived as a disease of
childhood, however with a significant adult prevalence
and incidence [12-14]. Both asthma [15] and ADHD
[16] have a clear genetic component. Asthma has a well
established co-morbid connection with psychiatric disor-
ders. Children with asthma have a higher prevalence of
behavioural difficulties than children without asthma
[17]. Among adult asthmatics, there is a higher preva-
lence of depression and anxiety disorders than in the
general population [18-20].
The pathophysiology and genetics of ADHD probably
involve multiple neurotransmitter systems, including
dopaminergic mechanisms [21], but a comprehensive
understanding of this disorder is still lacking. Pelsser,
Buitelaar & Savelkoul [22] have advanced the hypothesis
that ADHD may be a non-allergic hypersensitivity disor-
der, with pathophysiological links to asthma.C
Previous studies that have examined the potential rela-
tionship between ADHD and asthma have not presented
consistent results. Both a study of 140 boys with ADHD
[23] and a study of 140 girls with ADHD [24] failed to
find a positive association between ADHD and asthma.
However, in a large study from the National Survey of
Children’s Health in the USA, children with asthma
were more likely to have co-morbid ADHD compared
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with children without asthma [25]. A previous study on
adults, with data from a large claims database in the
USA, showed that ADHD was significantly associated
with asthma [26].
In a study using data from the Norwegian Prescription
Database we have shown that patients prescribed drugs
to treat ADHD also are prescribed anti-asthma drugs
significantly more often than the rest of the population
[27].
The aims of the present study were to (1) investigate
the prevalence of asthma among clinically diagnosed
adults with ADHD, compared to controls from a normal
population, and to (2) investigate if the presence of
asthma is associated with differences in symptom pat-




This is a cross-sectional study of 594 Norwegian
patients diagnosed with adult ADHD and a comparison
group of 719 persons from the general population. The
patients were recruited as part of a genetic study using a
national registry of adults diagnosed with ADHD in
Norway during 1997-May 2005 [11,21,28,29]. The diag-
nostic assessment of the patients in the registry was
made by one of three national expert committees for
ADHD, and was based on detailed clinical information
(including information from informants) provided by
the referring clinicians, mainly psychiatrists. The diagno-
sis of ADHD was made according to the ICD-10
research criteria, with two modifications; allowing the
inattentive subtype, as in DSM-IV, as sufficient for the
diagnosis, and allowing for the presence of co-morbid
psychiatric disorders, as long as the criteria for ADHD
were present before the appearance of the co-morbid
disorder.
To enhance recruitment and to include patients diag-
nosed also later than May 2005, psychiatrists and psy-
chologists nation-wide were invited to recruit formally
diagnosed adult patients with ADHD. The inclusion cri-
teria were a diagnosis of ADHD according to the criteria
described above, and age above 18 years. There were no
formal exclusion criteria. In the present paper we report
on data from a total of 594 patients, 340 from the
national registry, and 254 from the recruitment per-
formed after May 2005.
The control group was recruited using the database of
The Medical Birth Registry of Norway (MBRN). The
MBRN includes all people born in Norway after January
1st 1967. Invitation letters were sent out in 2007-2009
to a randomly selected sample of persons between 18-40
years from all over Norway. Data from the first 719 per-
sons recruited are presented in the present report. For
further details about the recruitment strategy and the
patient sample, see Johansson et al. 2008 [21], Halleland
et al. 2009 [28], Halmøy et al. 2009 [11], and Halmøy et
al. 2010 [29].
Informed consent based on detailed written informa-
tion about the project was obtained from all patients
and controls. The study was approved by the Regional
Research Ethical Committee of Western Norway.
Questionnaires
The following self-report questionnaires were used in
this study: The Wender Utah Rating Scale (WURS),
measuring the presence and frequency of childhood
ADHD symptoms [30], the Adult ADHD Self Report
Scale (ASRS) which measures the presence and fre-
quency of current symptoms of ADHD [31,32], and the
Mood Disorder Questionnaire (MDQ), a screening ques-
tionnaire for bipolar spectrum disorders (BSD) [33].
The WURS is designed to retrospectively record
symptoms and signs of ADHD in childhood. The ver-
sion of the scale used in this study contains 25 ques-
tions, each rated on a 5-point severity scale. The
WURS-25 has been validated by several investigators in
different countries and populations [34,35].
The ASRS is the World Health Organization’s (WHO)
rating scale for adult ADHD designed to measure cur-
rent ADHD symptoms. It consists of 18 items based on
DSM-IV symptoms/criteria for ADHD that are mea-
sured on a 5-point scale (0 = never/seldom and 4 = very
often), yielding a possible score range from 0-72. The
items 1-9 cover the symptoms of inattention; items 10-
18 the symptoms of hyperactivity and impulsivity. In
this study we used a continuous scoring method [32].
The MDQ is a screening instrument for BSD that has
been validated for use in the general population and in
psychiatric patient populations [33,36]. The MDQ con-
sists of 15 items. The first 13 questions concern periods
of life-time symptoms of mania and hypomania, and the
last two ask about co-occurrence of symptoms and
ranking of functional impairment caused by the symp-
toms. A standard MDQ positive score is defined as 7 or
more ‘yes’ on the first 13 items, ‘yes’ on question 14
(co-occurrence of symptoms) and level ‘3 or more’ on
question 15 (moderate to severe impairment).
In addition, self-reported data were collected concern-
ing socio-demographic and clinical factors including
educational and occupational levels and co-morbid
symptoms and problems. A diagnosis of asthma was
defined as answering yes to the following question:
“Have you ever had asthma?”
Statistical analyses
Bivariate associations were analysed using chi-square
tests, t-tests for independent samples, and logistic
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regression analyses. Multivariable associations between
ADHD and asthma were examined using a logistic
regression model with asthma as the outcome variable,
ADHD main predictor, and possible confounders age,
gender, education, anxiety/depression and bipolar disor-
der. All analyses were performed using the Statistical
Package for Social Sciences (SPSS) version 15.0.1.
Results
Clinical and socio-demographic characteristics of ADHD
patients and controls are shown in Table 1. In the con-
trol group there was a higher proportion of females
than in the patient group (59.4% vs. 48.3%), and the
mean age was lower (29.6 vs 34.0 years). The level of
education was lower in the patient group and the rela-
tive number holding an ordinary job was far lower. The
proportions of ADHD patients reporting a life-time his-
tory of depression and/or anxiety, bipolar disorder and
alcohol problems were significantly increased compared
to the controls, and scores on all the self report scales
for psychiatric symptoms were substantially higher in
the ADHD patient group than in the control group. All
these differences between ADHD patients and controls
were similar for males and females.
A total of 143 of the ADHD patients reported that they
had asthma (24.4%), compared with 81 (11.3%) of the
controls (OR = 2.53, 1.88-3.41, p < 0.001). Even after
controlling for age, gender, education, anxiety/depres-
sion, and bipolar disorder in a logistic regression analysis,
the OR only decreased slightly, and retained statistical
significance (Table 2). The frequency of self-reported
asthma was slightly, but not significantly, higher for
females in the control group compared with male con-
trols (12.7% vs. 9.2%, OR = 1.43, 0.88-2.34, chi square),
but significantly higher among the female ADHD
patients compared with the male ADHD patients (30.9%
vs. 18.2%, OR = 2.01, 1.36-2.95, p < 0.001, chi square).
Table 3 shows the same clinical and socio-demographic
characteristics as in Table 1 but this time contrasting
ADHD patients with and without asthma. Levels of educa-
tional and occupational activity were similar for patients
with and without asthma. More ADHD patients with
asthma reported a life-time history of depression and/or
anxiety than ADHD patients without asthma. This differ-
ence was still significant after controlling for age and gen-
der using logistic regression analysis (OR = 1.72, 1.11-2.69,
p = 0.016). However, whereas 83.6% of male ADHD
patients with asthma reported a history of depression and/
or anxiety compared with 61.1% in male ADHD patients
without asthma, the corresponding figures for female
ADHD patients with and without asthma were 72.7% and
71.8% respectively, indicating a potential gender-specific
effect, where males with asthma had a relatively higher
symptom load. MDQ-score was positive in a larger pro-
portion of ADHD patients with asthma, than in ADHD
patients without asthma. The reported levels of ADHD
symptoms in childhood (WURS), current ADHD symp-
toms (ASRS score) and self-reported history of bipolar dis-
order did not differ between the two groups.
The characteristics of controls with and without
asthma are shown in Table 4. Controls with asthma
were less likely to be employed compared to controls
without asthma. However, when controlling for age and
gender in a logistic regression analysis this difference
was no longer significant (OR = 0.57, 0.32-1.02). As for
the ADHD patients, self-reported depression and/or
anxiety was more prevalent in the asthma group, and
was still significant when controlling for age and gender
(OR = 2.10, 1.22-3.60, p = 0.007). Controls with asthma
had more often been diagnosed with bipolar disorders
and a larger percentage scored positively on the MDQ-
Table 1 Clinical and socio-demographic characteristics of
patients and controls
Patients Controls P
N = 594 N = 719
Age (mean ± SD) 34.0 ± 10.3 29.6 ± 6.5 < 0.001
Gender (% females) 48.3 59.4 < 0.001
Educational level (%)
Junior high school 26.3 4.0
Senior high school 50.0 36.4
College/university 23.7 59.5 < 0.001
Occupational level (%)
Working 29.1 80.5 < 0.001
Self reported co-morbidity (%)
Depression/anxiety 68.5 16.1 < 0.001
Bipolar disorder 11.2 1.4 < 0.001
Alcohol problems 23.1 2.1 < 0.001
WURS (score ± SD, range 0-100) 58.6 ± 17.9 17.5 ± 14.0 < 0.001
ASRS (score ± SD, range 0-72) 45.5 ± 12.3 22.9 ± 10.0 < 0.001
MDQ + (%) 48.2 6.3 < 0.001
Asthma(%) 24.4 11.3 < 0.001
Table 2 Results from binary logistic regression analysis
OR CI P
Unadjusted 2.54 1.89-3.44 < 0.001
Adjusted for:
age 2.75 2.02-3.73 < 0.001
+ gender 2.96 2.16-4.03 < 0.001
+ education 2.55 1.80-3.62 < 0.001
+ anxiety/depression 1.91 1.29-2.82 0.001
+ bipolar disorder 1.89 1.28-2.80 0.002
Odds ratios (ORs) with 95% confidence intervals (CIs) for having asthma given
a diagnosis of ADHD.
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questionnaire than controls without asthma. However,
these differences did not reach statistical significance.
Interestingly, even among controls, individuals with
asthma reported significantly higher levels of current
ADHD symptoms (ASRS score) or childhood symptoms
(WURS score) than the group without asthma.
Discussion
There are three main findings of the present study. The
first is that adult patients with ADHD significantly more
often reported a history of asthma, compared to a
control population. The second is that controls with
self-reported asthma reported more symptoms of
ADHD both in childhood and currently, compared to
controls without asthma. Finally, asthma in controls and
in male ADHD-patients was associated with self-
reported depression and/or anxiety.
The ADHD patients in the present study are very
impaired as a group, with a low level of education com-
pared to controls, and less than one third being
employed in ordinary work. This is in accordance with
previous studies showing a low level of occupational
functioning in adult patients with persistent ADHD
[10,11]. However, we found no indication that ADHD
patients with asthma represent a more impaired sub-
group of ADHD patients. The level of education,
employment status and scores on the ASRS and WURS
scales were not significantly different from ADHD
patients without asthma. Among the controls there was
a difference in employment status for patients with and
without asthma, but this difference disappeared when
controlling for age and gender.
Females in our control group had a slightly higher
prevalence of asthma compared to male controls, but
the difference was not statistically significant. Whereas
childhood asthma is more common in boys, adult
asthma is consistently more prevalent in females
[37-39], possibly related to hormonal factors [40,41].
In the previous clinical studies on the relationship
between ADHD and asthma where no association was
found [23,24], children only were examined. In a study
using data from the Norwegian Prescription Database,
we showed that patients prescribed drugs to treat
ADHD also were prescribed anti-asthma drugs signifi-
cantly more often than the population at large [27]. In
the prescription study we found a weaker relationship
between ADHD and asthma in the younger age groups
(< 20 years), than in the older age groups (> 20 years),
although the associations were significant across all
ages. Those findings, together with results from the cur-
rent study, the study from the National Survey of Chil-
dren’s Health by Blackman et al. [25], and on adults by
Secnik, Swensen & Lage [26], offer strong support for
the existence of a co-morbidity between ADHD and
asthma.
Such a co-morbidity may appear counterintuitive.
ADHD and asthma are very different disorders. ADHD
is a chronic disorder comprising problems with atten-
tion and concentration, combined with behavioural
symptoms such as hyperactivity/restlessness and impul-
sivity [2]. Asthma is a chronic inflammatory disorder of
the airways, with episodic worsening, and symptoms
related to the respiratory system. However, both ADHD
and asthma have similar co-morbid patterns with regard
to anxiety- and mood disorders. ADHD exhibits
Table 4 Clinical and socio-demographic characteristics of
controls with and without asthma
Asthma Not asthma P
N = 81 N = 636
Age (mean ± SD) 28.5 ± 6.7 29.8 ± 6.5 NS
Educational level (%)
Junior high school 2.5 4.3
Senior high school 45.0 35.2
College/university 52.5 60.6 NS
Occupational level (%)
Working 70.1 81.9 0.022
Self reported co-morbidity (%)
Depression/anxiety 27.2 14.5 0.003
Bipolar disorder 2.5 1.1 NS
Alcohol problems 4.9 1.7 NS
WURS (score ± SD, range 0-100) 22.1 ± 15.6 16.9 ± 13.7 0.008
ASRS (score ± SD, range 0-72) 26.0 ± 11.0 22.5 ± 9.8 0.003
MDQ + (%) 10.4 5.8 NS
Table 3 Clinical and socio-demographic characteristics of
patients with and without asthma
Asthma Not asthma P
N = 143 N = 441
Age (mean ± SD) 33.0 ± 10.2 34.5 ± 10.3 NS
Educational level (%)
Junior high school 30.5 24.8
Senior high school 51.6 49.6
College/university 18.0 25.6 NS
Occupational level (%)
Working 24.8 30.5 NS
Self reported co-morbidity (%)
Depression/anxiety 76.9 65.8 0.013
Bipolar disorder 13.3 10.6 NS
Alcohol problems 19.7 24.1 NS
WURS (score ± SD, range 0-100) 60.8 ± 17.2 57.9 ± 18.1 NS
ASRS (score ± SD, range 0-72) 45.6 ± 11.8 45.4 ± 12.5 NS
MDQ + (%) 57.8 45.3 0.013
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substantial co-morbidity with generalized anxiety disor-
der, panic disorder, depressive disorders, and bipolar
disorder in adults [9]. Asthma is to a similar degree
associated with the same anxiety disorders and with
bipolar disorder [42,43]. A large number of the ADHD
patients in our sample had co-morbid psychiatric disor-
ders [11,29], and male patients with asthma had a parti-
cularly high prevalence of depression and/or anxiety. In
the control group asthma was also associated with
depression and/or anxiety. It is therefore possible that
the association between ADHD and asthma is mediated
by these other co-morbid disorders.
Much of the current thinking on the pathophysiology
and genetics of ADHD has focused on alterations in
dopaminergic systems [21], and there is also substantial
evidence that dopaminergic mechanisms are involved in
mood disorders [44,45]. Dopaminergic systems have not
received a similar focus in pathophysiological research
on asthma, and are unlikely to explain the cause or
pathophysiology of asthma. It is however interesting to
note, that dopaminergic receptors are present in sensory
nerves in the airways [46], and inhaled dopamine is able
to induce bronchodilation during an acute asthma attack
[47]. It is therefore possible that changes in dopaminer-
gic systems, or perhaps other signalling mechanisms,
could explain part of the associations between ADHD
and asthma. Possibly, there could be a subgroup of
patients sharing underlying pathophysiological distur-
bances causing combined symptoms of asthma, ADHD,
mood- and anxiety disorders.
Other relevant factors that could help to explain this
co-morbidity may be due to risk behaviour associated
with ADHD, most notably tobacco smoking. Teenage
and adult patients with ADHD have a higher prevalence
of smoking in comparison with the general population
[48]. It is still a matter of controversy whether active
smoking is a cause of asthma, but it is certain to aggra-
vate symptoms among subjects that are prone to asthma
before they start smoking [49]. Unfortunately, in the
present study, we did not collect information on smok-
ing habits. Another possible etiological factor in relation
to tobacco is passive smoking in childhood [50] or pre-
natal exposure, since children with ADHD presumably
have been exposed to this to a larger extent than chil-
dren without ADHD [51]. Both passive smoking in
childhood and prenatal exposure is associated with an
increased risk for asthma, both in childhood [52] and
among adults [53].
Another possibility is that inflammatory mechanisms
may be a common factor for these disorders. Such
mechanisms are important in the pathophysiology of
asthma [54,55], are may be involved in mood disorders
[56,57], and are also postulated to be involved in ADHD
[58].
Both ADHD and asthma are associated with obesity.
Several studies have indicated a higher than expected
prevalence of obesity in ADHD patients [59], and obe-
sity is a risk factor for the development of asthma [60].
In regard to this it is also interesting that obesity leads
to a proinflammatory state [60]. Unfortunately we did
not collect obesity data in this study (body mass index,
waist circumference), so we cannot determine to what
extent this may have been a contributing factor.
Strengths and limitations
Concerning limitations it is evident that we are not study-
ing the whole range of ADHD patients. Not all patients
with such problems consult a doctor, and those that are
recruited to the present study probably represent a more
severely affected group [11]. It is therefore uncertain if the
present results are applicable to ADHD patients in general.
The ASRS, WURS and MDQ are well-known and widely
used auto-questionnaires, and even though they have not
been subject to official validations in Norway, validation
studies performed in various other populations have found
them suitable for use [11,29].
The diagnosis of asthma was made on the basis of
“yes-no” answers to a questionnaire. We made no quali-
fication that the diagnosis should have been given by a
doctor. In a study from Germany a fairly good agree-
ment was found between answers to such a question
compared to a subsequent interview by a physician [42].
Furthermore, we think it is probable that in a country
such as Norway, with a strongly subsidised health ser-
vice, people that think they have asthma will also have
consulted a doctor for such a condition. Still, it is possi-
ble that we may have underestimated the prevalence of
asthma, since Toren et al. [61] found that self-reported
asthma was biased in relation to disease severity, that
subjects with a mild disease were less prone to report
their asthma. On the other hand, the prevalence figure
from the control group (11.3%) is in fairly good agree-
ment with epidemiological studies from Norway. In a
report based on data from 1998/99 Brogger et al. [37]
found a 9.3% prevalence of asthma in Norwegian adults.
Conclusions
In conclusion, we have shown that adults patients with
persistent ADHD have an increased prevalence of
asthma compared to controls from the general popula-
tion, and that controls with asthma report higher levels
of both childhood and current ADHD symptoms. This
points to a co-morbidity between these two disorders,
possibly related to shared risk factors, pathophysiologies
and co-morbidities with mood and anxiety disorders.
We suggest that future studies should explore underly-
ing pathophysiological mechanisms that may explain the
co-occurrence of ADHD and asthma.
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